Degludec-Glargine Hospital Trial: A Randomized Controlled Trial Comparing Insulin and Glargine U100 for the Inpatient and Post-Hospital Discharge Management of Medicine and Surgery Patients With Type 2 Diabetes
Latest Information Update: 05 Apr 2022
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine (Primary) ; Insulin aspart
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 14 Jul 2021 Status changed from active, no longer recruiting to completed.
- 02 Mar 2021 Status changed from suspended to active, no longer recruiting.
- 02 Mar 2021 Planned End Date changed from 1 Dec 2020 to 1 Mar 2021.